Optimizing HER2 Assessment and Treatment in Advanced NSCLC: From Guidelines to the Clinic

Benjamin P Levy, MD, is Associate Professor of Oncology at the Johns Hopkins School of Medicine and serves as Clinical Director of the Sidney Kimmel Cancer Center, Johns Hopkins Medicine at Sibley Hospital in Washington DC. Prior to his Hopkins appointment, Dr Levy was Medical Director of Thoracic Oncology Program for Mount Sinai Health Systems in New York City and Associate Director of the Cancer Clinical Trials Office (CCTO). He is a physician scientist who is currently leading global immunotherapy trials evaluating checkpoint point inhibitors with novel combination strategies. In addition, he currently leads multiple targeted therapy trials with specific interest in EGFR mutations. Dr Levy has played an integral role on several American Society of Clinical Oncology (ASCO) committees and currently serves as editor-in-chief for the ASCO Self Evaluation Program (SEP). He is an ad hoc reviewer for Clinical Cancer Research, the Annals of Oncology, and the Journal of Clinical Oncology. He was recently selected as one of only 15 oncologist in the country to the prestigious ASCO Leadership Development Program whose mission is to identify and develop future leaders of ASCO. Dr Levy serves on the IASLC Staging Committee and IASLC Career Development & Fellowship Committee.

• LinkedIn